According to research published in the National Library of Medicine, blood naturally moves more slowly through the deep veins of the legs than in many other parts of the body. This happens because gravity works against the upward flow of blood and because the legs are located far from the heart. As a result, this region is particularly vulnerable to the development of blood clots.

When abnormal clotting signals circulate throughout the body, the legs are one of the most frequent locations where a blockage can develop. As a clot begins to form, it disrupts normal blood flow and quickly leads to swelling and inflammation in the affected area. Some individuals may also notice pain, warmth, or redness, but for many patients the only visible warning sign is swelling in the leg.

Statistical Risks: The Khorana Score

Clinical evidence consistently confirms a strong relationship between pancreatic cancer and disorders involving blood clots. Among all cancers, pancreatic cancer ranks second for the risk of developing venous thromboembolism (VTE), a condition that includes both deep vein thrombosis (DVT) and pulmonary embolism.

Recent estimates from 2024 and 2025 suggest that roughly 20% to 40% of people with advanced pancreatic cancer will experience a clotting event at some point during the course of their illness. This makes clotting disorders one of the most frequent complications associated with the disease.

The Khorana Risk Score

To determine which cancer patients face the highest likelihood of developing blood clots, clinicians often rely on a predictive tool known as the Khorana Risk Score. This model assesses several factors, including the type of cancer involved, platelet levels, hemoglobin concentration, and body mass index.

Each cancer type is assigned a baseline score based on its known risk of causing clotting problems. Pancreatic cancer automatically receives two points, placing patients directly into the high-risk category even before other risk factors are taken into account.

Prognostic Significance

For individuals with pancreatic cancer, blood clots are not merely a complication of the disease—they may also provide insight into how severe the cancer is. Research connected to the COMPASS trial in 2025 suggests that the early appearance of clots may be linked to particularly aggressive tumor subtypes.

When venous thromboembolism occurs within the first three months after diagnosis, it is often associated with tumors that have biological characteristics promoting faster growth and poorer survival outcomes. Because of this connection, doctors view sudden or unexplained leg swelling as a possible warning sign that the disease may progress more aggressively.

Protein Deficiencies and Systemic Edema

Not all swelling associated with pancreatic disease is caused by blood clots. In certain cases, swelling may appear in both legs due to a condition called systemic edema, which occurs when the body’s fluid balance becomes disrupted, according to the Mayo Clinic.

Albumin, a protein produced by the liver, plays a key role in keeping fluid contained within the blood vessels. When albumin levels drop too low, fluid begins to leak out of the vessels and accumulate in surrounding tissues, resulting in swelling.

Pancreatic tumors can interfere with this process because they may block the release of important digestive enzymes. Without these enzymes, the body struggles to properly absorb proteins from food. Over time, this can lead to a condition known as hypoalbuminemia, particularly in more advanced stages of the disease. In some cases, the tumor may also affect liver function or trigger widespread inflammation in the body, both of which can further reduce albumin levels.

This type of swelling commonly appears as pitting edema, which is usually most noticeable around the ankles and feet. A simple way to check for pitting edema is by gently pressing a finger into the swollen area—if a temporary indentation remains, it may indicate this condition. Unlike swelling caused by DVT, which typically affects only one leg, systemic edema usually develops gradually and tends to involve both legs.

Diagnostic Pathways: When Swelling Leads to Discovery

In some cases, swelling in the legs may be the earliest sign that leads to the discovery of pancreatic cancer. Because of this possibility, medical guidelines—such as those released by ESMO in 2025—recommend careful medical evaluation when leg swelling appears without a clear explanation. This recommendation is particularly important for individuals over the age of 50 or those with additional risk factors, including a history of smoking or unexplained weight loss.

The diagnostic process for possible pancreatic disease usually begins with initial testing. Doctors often start with a blood test that measures D-dimer levels, proteins that appear when the body is breaking down a blood clot. Research published by Seitz and colleagues in 2024 showed that elevated D-dimer levels can indicate the presence of a clot, although the test alone cannot confirm a diagnosis.

If deep vein thrombosis (DVT) is suspected, physicians typically proceed with imaging tests. According to the Mayo Clinic, one of the first methods used is duplex ultrasound, which allows doctors to observe blood flow in the veins and determine whether it has slowed or become blocked.

Another important step involves identifying any underlying cancers. When DVT occurs without an obvious trigger—such as recent surgery or long-distance travel—it is considered unprovoked. In such situations, the National Cancer Institute noted in 2025 that physicians may order abdominal CT or MRI scans to search for hidden cancers, including pancreatic cancer. Investigating unexplained clotting events can sometimes lead to the detection of cancer at an earlier stage than would normally occur.

Management and Emerging Treatment Strategies (2025–2026)

When leg swelling is linked to pancreatic cancer, treatment focuses both on relieving the swelling and addressing the underlying cause.

Anticoagulation Therapy

Once a blood clot is identified, doctors commonly prescribe anticoagulant medications such as Direct Oral Anticoagulants (DOACs) or Low-Molecular-Weight Heparins (LMWH). These medications help prevent the clot from enlarging and reduce the risk of new clots forming. They also significantly lower the chance of severe complications, including pulmonary embolism.

Preventive Strategies

Recent findings reported in the ASCO Post suggest that patients considered at high risk may benefit from preventive use of blood-thinning medications at the time of their cancer diagnosis in order to reduce the likelihood of clot formation.

Supportive Care

In addition to medical treatment, certain practical measures can help relieve symptoms and reduce fluid buildup. According to the Mayo Clinic, helpful steps include:

Wearing compression stockings to improve circulation

Elevating the legs while resting

Staying physically active through light exercise such as walking

To see the full instructions for this recipe, go to the next page or click the open button (>) and don't forget to share it with your friends on Facebook.